Sign in
  Edit search
Imiquimod 5%252525 cream for the treatment of actinic kerato…
Imiquimod 5%252525 cream for the treatment of actinic keratosis%25253A results from a phase III%25252C randomized%25252C double-blind%25252C vehicle-controlled%25252C clinical trial with histology.
Imiquimod 5%252525 cream for the treatment of actinic keratosis%25253A results from a phase III%25252C randomized%25252C double-blind%25252C vehicle-controlled%25252C clinical trial with histology.
Article, Chapter
Authors: R.M. Szeimies
Publication: Journal of the American Academy of Dermatology, Volume:51, Issue:4, Page(s):547-555
Published: Mosby, 2004
ISSN: 0190-9622
  Full text availability for this item
View Full Text Source:Journal of the American Academy of Dermatology,Journal of the American Academy of Dermatology,Elsevier ScienceDirect Journals Opens in new Window
Journal:  Journal of the American Academy of Dermatology Source:Elsevier ScienceDirect Journals Opens in new Window
Collection:  Elsevier ScienceDirect Journals Opens in new Window
Coverage:
  • 1979-07~present; volume:1~present;issue:1~present
Browse related articles
  Print copies at your library
Check availability in RUQuest
  Request a copy of this item
Cite this item